Objectives: Methemoglobinemia (MetHb) is a rare condition that may have mortal consequences. Literature shows cases of methemoglobinemia due to the use of lidocaine and other local anesthetics. This is a cross-sectional study to determine the incidence of methemoglobinemia after the application of lidocaine. Methods: In this study, 88 patients admitted to the emergency department of a university hospital between May 2014 and May 2015 and needed lidocaine application for small surgical procedures were included. When compared before and after the administration of lidocaine <2 mg/kg and >2 mg/kg, there was not a significant difference in the level of methemoglobin, hemoglobin, or in the hematocrit (p=0.604, p=0.502, and p=0.367, respectively). Results: Mean age of the patients was 33.85 (±17.58) years, and 83% of the patients were male. Methemoglobin levels were not significantly different before and after the procedures (p>0.05).
Introduction
Iron in hemoglobin is bivalent under normal conditions (Fe ++ ). Methemoglobinemia (MetHb) occurs after the oxidation of hemoglobin iron to ferric (Fe +3 ) form. [1] If methemoglobinemia is severe, the transportation of oxygen and carbon dioxide in blood fails and hypoxia, lactic acidosis, and death may occur. [2] Both hereditary and acquired methemoglobinemia are possible. Methemoglobinemia can be due to the lack of NADH diaphorase, cytochrome b-5, and glucose-6-P dehydrogenase, which reduce methemoglobin , as well as presence of abnormal hemoglobin. [1] Many substances or drugs, including amino benzenes, benzocaine, dapsone, phenytoin, phenacetin, nitrites, nitrates, chlorates, kinins, nitrobenzene, nitrotoluen, chloroquine, sulphonamides, and local anesthetics such as lidocaine (xylocaine), reportedly cause acquired methemoglobinemia. [3] Local anesthetics are routinely used before invasive procedures. Lethal methemoglobinemia cases are particularly reported after benzocaine application. [4] Lidocaine is one of the most common local anesthetics because of its short-acting profile. It is an amid type local anesthetic that has side effects, such as dizziness, numbness around the mouth and tongue, ataxia, agitation, convulsions, respiratory depression, coma, and cardiovascular collapse. [5] There are case reports of methemoglobinemia due to lidocaine in infants and adults in the literature, although they are rare. [6, 7] Therefore, we performed a cross-sectional study to determine the incidence of methemoglobinemia after the application of lidocaine for small surgical procedures in an emergency department.
Materials and Methods
In this study, we included the patients that were admitted to the emergency department between May 2014 and May 2015 who received Jetokain Ampoule® for small surgical procedures after trauma. Jetokain Ampoule® includes lidocaine hydrochloride (20 mg/dl) and epinephrine base (0.0125 mg/ml). There were no age limitations in this cross-sectional study, and all patients who received Jetokain Ampoule® were included. Ethics Committee approval (KAI-58-14.05.2015) was obtained. In addition, informed consent was obtained from patients participating in the study. In total, 124 patients who underwent small surgical procedures were included. Those who did not want to participate in the study were excluded. In addition, patients who left the emergency department and did not wait for 45 minutes after their surgical procedure for a second blood gas test were excluded.
Data were collected with a data collection form. The demographic characteristics of the patients were noted in the first part of the form. The type of the procedure, the dose of applied lidocaine, and patients' MetHb values before and after the application were noted in the second part of the form. In addition, hemoglobin and hematocrit values of the patients were noted. The ABL90 FLEX blood gas evaluation device was used for the assessment in hospital laboratories. No medication was administrated during or after these procedures.
The dose of lidocaine was determined according to the size of cut present in patients. Lidocaine was administered by the emergency physician under the skin of the wound edges using an insulin syringe. MetHb values were taken in the blood gas before lidocaine application. Forty-five minutes after lidocaine application, patients were evaluated clinically, and methemoglobin values were taken in the venous blood gas. Weight of the patients was checked using a Jawo PLUS II electronic scale.
Statistical analysis
The data analysis was performed using the Statistical Package for the Social Sciences for Windows, version 21.0 (SPSS Inc, Chicago, IL, USA). Whether the distributions of continuous variables were normal was determined by Kolmogorov-Smirnov test. Data were shown as mean±standard deviation or median (min-max) values, where applicable. The differences between groups were compared by using Student's t or Mann-Whitney U test, as appropriate. Categorical data were analyzed using Pearson's chi-square test, where appropriate. A p value less than 0.05 was considered statistically significant.
Results
The mean age of the 88 patients was 33.85 years (±17.58 years); 83% of the patients were male, 94.3% did not have any comorbid disease, 4.6% had coronary artery disease, 1.1% had chronic renal failure, 19.3% were smokers, and 5.7% consumed alcohol. The median lidocaine dosage administered was 40 mg/dL (range: 20-280 mg/dL), and the average weight of the patients was 67.51±11.52 kg. The median lidocaine dose was 0.73 mg/kg (range: 0.22-5.71 mg/kg). Overall, 92% of the patients were given less than 2 mg/kg of lidocaine. The median methemoglobin level after lidocaine application was 0.85% (range: 0.10-7.60%). Table 1 and after minor surgical procedures. There was no significant difference in the methemoglobin level before and after the procedures. Table 2 shows the patients' methemoglobin level according to a lidocaine dose of less than 2 mg/kg or more than 2 mg/kg. Only 3.8% of the patients who were given less than 2 mg/kg of lidocaine had a high methemoglobin level. The methemoglobin level based on a dose of lidocaine of less than or more than 2 mg/kg was statistically insignificant (p=0.604). Table 3 shows the patients' hemoglobin (Hb) and hematocrit (Htc) levels according to the application of lidocaine doses less than 2 mg/kg or more than 2 mg/kg. Hb and Htc levels according to the application of lidocaine less than or more than 2 mg/kg are statistically insignificant (p=0.502 and p=0.367).
Discussion
There are reported cases of methemoglobinemia after lidocaine application; however, there is no largescale incidence study about methemoglobinemia after lidocaine application for small surgical procedures. Therefore, we believe that our study makes an important contribution to the literature. [8, 9] MetHb diagnosis is based on clinical and laboratory findings. Central or peripheral cyanosis may develop in patients according to oxygen saturation levels.
Chocolate colored blood is suggestive of MetHb, but
MetHb may develop in other colors as well. [10] Pulse oximetry cannot diagnose MetHb because it cannot show the level of desaturation. The diagnosis of methemoglobinemia can be made by blood gas analysis and use of co-oximeter to determine the difference between low arterial oxyhemoglobin saturation (SaO 2 ) and high pressure of arterial oxygen (SpO 2 ). [11] If the difference between SaO 2 -SpO 2 is more than 5%, the patient has the tendency toward MetHb. [13] Under normal conditions, blood MetHb levels should be less than 1.5%. [7, 13] If MetHb values are more than 5% g/dL, cyanosis can be observed. When the MetHb value is greater than 40%, an increase in cyanosis, respiratory distress, dizziness, headache, tachycardia, weakness, nausea, vomiting, lethargy, or syncope may be observed. [13, 14] When the MetHb level is more than 60%, likelihood of mortality increases; in more than 70% cases, it is lethal. [15] Notably, there is no relationship between symptoms and the level of MetHb. [16] According to our study, there is increase in blood MetHb levels after minor surgical procedures rather than before; however, there are no significant clinical changes and lidocaine does not appear to contribute to the development of methemoglobinemia. Lidocaine is primarily used in esophagogastroduodenoscopy and fiberoptic bronchoscopy; methemoglobinemia due to lidocaine application is mostly seen after lower respiratory tract or gastrointestinal tract procedures. [11, 16] Methemoglobinemia following these procedures may develop due to absorption from mucous membranes.
Lidocaine is metabolized in the liver by the cytochrome P450 3A4 enzyme. Its 96-minute half-life is the shortest among anesthetic agents. When lidocaine is used alone, the maximum dose is 4-5 mg/ kg or 300 mg. [17] When used in combination with epinephrine, the dose may be up to 7 mg/kg or 500 mg, if tolerated. [17] According to our study, changes in the level of MetHb based on differences in lidocaine doses administered for minor surgical procedures were not statistically significant. Although it is true it might be due to "Jetokain Ampoule®, " which includes epinephrine base. In the literature, lidocaine-related methemoglobinemia cases are rare. In his retrospective study, Guay [10] implied that three patients devel- oped lidocaine-related methemoglobinemia with an incidence of 1%. Neuhaeuser et al. [6] stated that 20% of infants had elevated levels of MetHb after lidocaine administration in pediatric craniofacial surgery. MetHb cases have also been reported due to use of lidocaine in combination with other drugs. [11] Although it is not evaluated in our study, MetHb also can develop due to ingestion of nitrates in drinking water or food, dehydration, use of various drugs, and cardiac or respiratory system diseases. [18] Therefore, it is important to consider these factors. Methemoglobinemia is a rare but potentially lethal condition. Clinical signs of MetHb can vary; therefore, personnel working in emergency departments need to have information about circumstances that lead to the development of MetHb and the signs, symptoms, and treatment of the disease. Lidocaine and other anesthetics are often used in emergency departments. Therefore, health staff working in emergency departments need to identify the patients with risk factors and should take a relevant history from new patients.
